Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : NVS save search
AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory Committee
Published: 2024-03-25 (Crawled : 12:00) - globenewswire.com
NVSEF | $93.6375 82K
|
Health Technology
|
| O: -100.0%
H: NaN%
C: Infinity%
NVS | $92.99 -1.5% 990K
|
Health Technology
|
| O: -0.08%
H: 0.15%
C: -0.44%
AUTL | $4.94 0.82% 210K
|
Health Technology
|
| O: 2.53%
H: 1.85%
C: -2.31%
medical
Novartis Fabhalta® (iptacopan) receives positive CHMP opinion as first oral monotherapy for adult patients with paroxysmal nocturnal hemoglobinuria (PNH)
Published: 2024-03-22 (Crawled : 12:00) - globenewswire.com
NVS | $92.99 -1.5% 990K
|
Health Technology
|
| O: 0.17%
H: 0.28%
C: -0.01%
fabhalta first chmp positive novartis
MorphoSys Announces U.S. Antitrust Clearance of Proposed Acquisition by Novartis Under HSR Act
Published: 2024-03-22 (Crawled : 08:00) - biospace.com/
NVS | $92.99 -1.5% 990K
|
Health Technology
|
| O: 0.17%
H: 0.28%
C: -0.01%
MOR | $17.985 -0.19% 330K
|
Health Technology
|
| O: 0.94%
H: 0.11%
C: -0.11%
acquisition clearance novartis
Global OTC Artificial Tears Analysis Report 2023-2030: The Influence of Smart Technologies, Market Positioned for Continued Expansion Amid Growing Focus on Eye Wellness
Published: 2024-03-21 (Crawled : 00:00) - prnewswire.com
NVS | $92.99 -1.5% 990K
|
Health Technology
|
| O: 0.17%
H: 0.28%
C: -0.01%
JNJ | $145.405 -1.48% 7.6M
|
Health Technology
|
| O: 0.02%
H: 0.0%
C: 0.0%
BHC | $8.595 -0.41% 880K
|
Health Technology
|
| O: -0.74%
H: 1.54%
C: 1.38%
ABBV | $163.42 1.08% 2M
|
Health Technology
|
| O: 0.16%
H: 0.0%
C: 0.0%
report expansion global wellness smart growing eye market
BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer
Published: 2024-03-20 (Crawled : 10:00) - globenewswire.com
NVSEF | $93.6375 82K
|
Health Technology
|
| O: -1.37%
H: 0.0%
C: -1.58%
NVS | $92.99 -1.5% 990K
|
Health Technology
|
| O: -0.62%
H: 0.45%
C: 0.34%
BNTX | $87.1 -0.9% 540K
|
Health Technology
|
| O: -5.51%
H: 1.33%
C: 1.2%
management commercial
Monoclonal Antibody (mABs) Therapeutics Market Worth $497.5 billion | MarketsandMarkets™
Published: 2024-03-15 (Crawled : 14:30) - prnewswire.com
TAK | $13.235 0.42% 710K
|
Health Technology
|
| O: 0.21%
H: 0.97%
C: 0.7%
NVS | $92.99 -1.5% 990K
|
Health Technology
|
| O: 0.05%
H: 0.14%
C: -0.93%
JNJ | $145.405 -1.48% 7.6M
|
Health Technology
|
| O: -1.58%
H: 0.0%
C: 0.0%
LLY | $749.215 -0.21% 1.4M
|
Health Technology
|
| O: -0.7%
H: 0.73%
C: -0.16%
ABBV | $163.42 1.08% 2M
|
Health Technology
|
| O: -0.07%
H: 0.0%
C: 0.0%
SNY | $46.19 0.57% 580K
|
Health Technology
|
| O: -0.02%
H: 0.0%
C: 0.0%
REGN | $895.92 -0.29% 310K
|
Health Technology
|
| O: -0.27%
H: 1.26%
C: 0.84%
AMGN | $264.955 -0.21% 880K
|
Health Technology
|
| O: 0.2%
H: 1.14%
C: -1.18%
antibody therapeutics market
Pharmaceutical Continuous Manufacturing Market to grow by USD 548.94 million, 35% of market growth is expected in North America, Technavio
Published: 2024-03-14 (Crawled : 14:00) - prnewswire.com
NVSEF | $93.6375 82K
|
Health Technology
|
| O: 0.75%
H: 1.17%
C: 1.17%
TMO | $555.75 -0.38% 380K
|
Health Technology
|
| O: -0.39%
H: 0.7%
C: -1.03%
NVS | $92.99 -1.5% 990K
|
Health Technology
|
| O: -0.6%
H: 0.07%
C: -0.28%
HON | $191.25 -1.44% 1.3M
|
Producer Manufacturing
|
| O: -0.24%
H: 0.24%
C: -1.46%
expected growth market
MorphoSys AG Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Published: 2024-03-13 (Crawled : 23:00) - biospace.com/
NVSEF | $93.6375 82K
|
Health Technology
|
| O: -0.23%
H: 0.0%
C: 0.0%
NVS | $92.99 -1.5% 990K
|
Health Technology
|
| O: -0.07%
H: 0.09%
C: -0.7%
XNCR | $19.08 -5.12% 170K
|
Health Technology
|
| O: -0.66%
H: 4.19%
C: 3.13%
MOR | $17.985 -0.19% 330K
|
Health Technology
|
| O: 0.22%
H: 0.22%
C: -0.93%
INCY | $53.725 0.55% 630K
|
Health Technology
|
| O: 0.03%
H: 1.47%
C: -0.72%
year update financial results
Global Irritable Bowel Disease (IBD) Market Research Report 2024: Corticosteroids, JAK inhibitors, TNF inhibitors, Other Drug Classes Insights and Forecast 2019-2029
Published: 2024-03-13 (Crawled : 03:00) - prnewswire.com
NVSEF | $93.6375 82K
|
Health Technology
|
| O: -0.23%
H: 0.0%
C: 0.0%
NVS | $92.99 -1.5% 990K
|
Health Technology
|
| O: -0.07%
H: 0.09%
C: -0.7%
JNJ | $145.405 -1.48% 7.6M
|
Health Technology
|
| O: 0.66%
H: 0.0%
C: 0.0%
LLY | $749.215 -0.21% 1.4M
|
Health Technology
|
| O: 0.27%
H: 0.5%
C: 0.11%
ABBV | $163.42 1.08% 2M
|
Health Technology
|
| O: 0.59%
H: 0.01%
C: -1.45%
drug disease report research global market
Global IgG Mediated Autoimmune Diseases Biologic Drugs Research Report 2023-2029: Shift Towards Personalized Medicine and Targeted Therapies & Adoption of Biosimilars and Biobetters
Published: 2024-03-13 (Crawled : 01:00) - prnewswire.com
NVSEF | $93.6375 82K
|
Health Technology
|
| O: -0.23%
H: 0.0%
C: 0.0%
NVS | $92.99 -1.5% 990K
|
Health Technology
|
| O: -0.07%
H: 0.09%
C: -0.7%
JNJ | $145.405 -1.48% 7.6M
|
Health Technology
|
| O: 0.66%
H: 0.0%
C: 0.0%
LLY | $749.215 -0.21% 1.4M
|
Health Technology
|
| O: 0.27%
H: 0.5%
C: 0.11%
ABBV | $163.42 1.08% 2M
|
Health Technology
|
| O: 0.59%
H: 0.01%
C: -1.45%
SNY | $46.19 0.57% 580K
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
report research global
Biologics Contract Development And Manufacturing Organization (CDMO) Market to grow by USD 10.63 billion, The availability of cost-efficient resources to boost market growth, Technavio
Published: 2024-03-12 (Crawled : 05:00) - prnewswire.com
GIKLY | $4.56 260
|
Manufacturing
|
| O: -4.79%
H: 0.0%
C: -0.23%
NVSEF | $93.6375 82K
|
Health Technology
|
| O: 2.2%
H: 0.0%
C: -2.57%
NVS | $92.99 -1.5% 990K
|
Health Technology
|
| O: -1.55%
H: 0.23%
C: -0.03%
ABBV | $163.42 1.08% 2M
|
Health Technology
|
| O: 1.04%
H: 0.0%
C: 0.0%
contract market
Global Dilated Cardiomyopathy (DCM) Market Report 2024, with Company Profiles of the Top 10 Major Market Players
Published: 2024-03-07 (Crawled : 00:00) - prnewswire.com
AZNCF | $135.94 770
|
Health Technology
|
| O: 3.21%
H: 0.0%
C: -1.71%
NVS | $92.99 -1.5% 990K
|
Health Technology
|
| O: 0.08%
H: 0.86%
C: 0.7%
JNJ | $145.405 -1.48% 7.6M
|
Health Technology
|
| O: -0.68%
H: 0.0%
C: 0.0%
LLY | $749.215 -0.21% 1.4M
|
Health Technology
|
| O: -0.02%
H: 0.0%
C: -2.29%
ABT | $109.92 0.95% 3.2M
|
Health Technology
|
| O: 0.58%
H: 0.0%
C: 0.0%
SNY | $46.19 0.57% 580K
|
Health Technology
|
| O: -0.08%
H: 0.0%
C: 0.0%
AZN | $68.38 -0.51% 2.1M
|
Health Technology
|
| O: -0.03%
H: 0.62%
C: 0.5%
AMGN | $264.955 -0.21% 880K
|
Health Technology
|
| O: -0.02%
H: 1.37%
C: 0.34%
company report global market
Alkermes Announces Appointment of Nancy S. Lurker to Board of Directors
Published: 2024-03-07 (Crawled : 12:00) - prnewswire.com
PFE A | $25.73 -0.7% 17M
|
Health Technology
|
| O: 0.04%
H: 0.44%
C: -1.51%
NVS | $92.99 -1.5% 990K
|
Health Technology
|
| O: -2.08%
H: 0.13%
C: -0.57%
BMY | $48.365 -0.3% 4.9M
|
Health Technology
|
| O: 0.36%
H: 0.34%
C: -0.54%
XFOR | $1.265 1.2% 1.2M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: -4.98%
EYPT | $21.81 2.49% 140K
|
Health Technology
|
| O: 2.56%
H: 1.37%
C: -4.13%
AQST | $3.77 -4.32% 1.3M
|
Health Technology
|
| O: 1.79%
H: 12.3%
C: 10.94%
ALKS | $23.85 -0.71% 530K
|
Health Technology
|
| O: 1.11%
H: 0.96%
C: 0.65%
Clinical trials market size in US to grow by USD 5.9 billion from 2022 to 2027, The rise in the number of clinical trials of drugs is the key factor driving market growth, Technavio
Published: 2024-03-06 (Crawled : 12:00) - prnewswire.com
SNYNF | $92.966 630
|
Health Technology
|
| O: 0.0%
H: 0.8%
C: 0.8%
TMO | $555.75 -0.38% 380K
|
Health Technology
|
| O: 0.64%
H: 1.7%
C: 0.54%
NVS | $92.99 -1.5% 990K
|
Health Technology
|
| O: 0.2%
H: 0.71%
C: 0.33%
SNY | $46.19 0.57% 580K
|
Health Technology
|
| O: -0.45%
H: 0.0%
C: 0.0%
ICLR | $295.56 -1.19% 260K
|
Health Technology
|
| O: 2.54%
H: 0.22%
C: -2.44%
trials key market
Global Respiratory Syncytial Virus Diagnostics Market Report 2024-2029: Rising Healthcare Expenditure, Technological Innovations, and Increased Incidence of RSV Fueling Growth
Published: 2024-03-05 (Crawled : 05:00) - prnewswire.com
TMO | $555.75 -0.38% 380K
|
Health Technology
|
| O: -0.09%
H: 0.86%
C: 0.6%
DGX | $128.31 -0.26% 220K
|
Health Services
|
| O: 0.38%
H: 0.69%
C: -1.01%
NVS | $92.99 -1.5% 990K
|
Health Technology
|
| O: 0.32%
H: 0.22%
C: -0.2%
BIO | $295.38 -1.67% 72K
|
Health Technology
|
| O: -0.53%
H: 1.08%
C: -0.59%
ABT | $109.92 0.95% 3.2M
|
Health Technology
|
| O: 1.6%
H: 0.0%
C: 0.0%
QDEL | $40.585 -2.09% 470K
|
Health Technology
|
| O: 0.18%
H: 1.13%
C: -3.31%
report respiratory global rsv virus diagnostics growth market
Janus Kinase (JAK) Inhibitors Global Market Report 2024, Featuring Key Players Pfizer, Merck, AbbVie, Novartis, Sanofi, Bristol Myers Squibb, GSK, Takeda, Eli Lilly and Gilead Sciences
Published: 2024-03-05 (Crawled : 01:00) - prnewswire.com
NVS | $92.99 -1.5% 990K
|
Health Technology
|
| O: 0.32%
H: 0.22%
C: -0.2%
ABBV | $163.42 1.08% 2M
|
Health Technology
|
| O: -0.24%
H: 0.0%
C: 0.0%
SNY | $46.19 0.57% 580K
|
Health Technology
|
| O: 1.17%
H: 0.0%
C: 0.0%
report sciences global key market
Novartis presents new data on safety and efficacy of Zolgensma, including maintained and improved motor milestones in older and heavier children with SMA
Published: 2024-03-04 (Crawled : 07:00) - globenewswire.com
NVS | $92.99 -1.5% 990K
|
Health Technology
|
| O: -0.6%
H: 0.68%
C: 0.51%
children novartis
Urinary Tract Infection Treatment Market Projected to Reach US$ 10.73 Billion by 2030: Telemedicine Integration Revolutionizes UTI Care, Self-Care Products Gain Momentum
Published: 2024-02-29 (Crawled : 20:00) - prnewswire.com
GLAXF | $20.2 510
|
Health Technology
|
| O: -2.33%
H: 3.68%
C: 2.44%
NVSEF | $93.6375 82K
|
Health Technology
|
| O: 0.89%
H: 0.0%
C: 0.0%
NVS | $92.99 -1.5% 990K
|
Health Technology
|
| O: 1.03%
H: 0.14%
C: 0.05%
JNJ | $145.405 -1.48% 7.6M
|
Health Technology
|
| O: 0.28%
H: 0.0%
C: 0.0%
GSK | $40.035 -1.15% 1.5M
|
Health Technology
|
| O: 0.26%
H: 0.18%
C: 0.05%
BMY | $48.365 -0.3% 4.9M
|
Health Technology
|
| O: 0.37%
H: 0.27%
C: -0.1%
integration reach momentum infection treatment market
Global Dermatological Drugs Market Set to Surpass US$30 Billion with Advanced Nanotechnology and Aging Population Fostering Growth
Published: 2024-02-28 (Crawled : 11:00) - prnewswire.com
ROIV | $10.805 -0.32% 2.8M
|
Manufacturing
|
| O: -0.76%
H: 0.51%
C: 0.0%
NVS | $92.99 -1.5% 990K
|
Health Technology
|
| O: 0.05%
H: 0.06%
C: -0.95%
JNJ | $145.405 -1.48% 7.6M
|
Health Technology
|
| O: 0.67%
H: 0.0%
C: 0.0%
ABBV | $163.42 1.08% 2M
|
Health Technology
|
| O: 0.6%
H: 0.02%
C: -1.03%
global set dermatological advanced growth market
Global Antibiotic Drugs Market Report 2024-2029: A $50.41 Billion Industry in 2022 - Focus on United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Japan, India
Published: 2024-02-28 (Crawled : 03:00) - prnewswire.com
VTRS | $11.15 -1.5% 2.3M
|
Health Technology
|
| O: -0.15%
H: 2.57%
C: -6.96%
NVS | $92.99 -1.5% 990K
|
Health Technology
|
| O: 0.05%
H: 0.06%
C: -0.95%
JNJ | $145.405 -1.48% 7.6M
|
Health Technology
|
| O: 0.67%
H: 0.0%
C: 0.0%
ABT | $109.92 0.95% 3.2M
|
Health Technology
|
| O: 1.12%
H: 0.52%
C: 0.47%
report india global market
Gainers vs Losers
| 54% | 46% |
Top 10 Gainers
WISA 4 | $7.86 349.14% 120M
|
Electronic Technology
TPET | $0.4951 114.24% 29M
|
n/a
JAGX | $0.1771 49.07% 540M
|
Health Technology
SXTC | $2.03 45.0% 27M
|
Health Technology
SPCB | $0.3888 40.87% 27M
|
Electronic Technology
DYNT | $0.52 40.39% 20M
|
Health Technology
SNGX | $0.54 39.86% 7.3M
|
Health Technology
BSGM | $1.53 39.09% 2.6M
|
Health Technology
MCBC | $13.74 38.37% 1.6M
|
Finance
PALI | $5.51 32.45% 28M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.